How should orthostatic hypotension be managed in a patient taking antihypertensive medication?

Management of Orthostatic Hypotension in Patients on Antihypertensive Medication

Do not simply reduce or stop blood pressure medications when orthostatic hypotension occurs—instead, switch to alternative antihypertensive agents that are less likely to worsen orthostatic hypotension while maintaining blood pressure control. 1

Initial Assessment and Screening

Before starting or intensifying any BP-lowering medication, screen for orthostatic hypotension by having the patient sit or lie for 5 minutes, then measure BP at 1 and/or 3 minutes after standing 1. Orthostatic hypotension is defined as a drop of ≥20/10 mmHg (systolic/diastolic) 2, 3.

Check standing BP regularly when titrating antihypertensive therapy, and assess for volume depletion and autonomic dysfunction 2.

Treatment Algorithm

Step 1: Non-Pharmacological Interventions (First-Line)

Non-pharmacological approaches are the recommended first-line treatment for orthostatic hypotension in patients with supine hypertension 1:

• Adequate hydration and salt intake: Target 2-3 L of fluids per day and 10 g of NaCl 4
• Abdominal binders and compression stockings: Reduce venous pooling 4, 5
• Head-up tilt sleeping (10°): Prevents nocturnal polyuria, maintains favorable body fluid distribution, and ameliorates nocturnal hypertension 4, 5
• Physical counterpressure maneuvers: Leg crossing and squatting for patients with warning symptoms 4
• Rapid cool water ingestion: Effective for combating orthostatic intolerance and post-prandial hypotension 4

Step 2: Medication Review and Optimization

Identify and eliminate drugs that worsen orthostatic hypotension, including easily overlooked medications such as:

• Alpha-blockers (tamsulosin, doxazosin) 3, 5
• Sedatives 1
• Prostate-specific alpha-blockers 1
• Tricyclic antidepressants 6
• Tizanidine, sildenafil, trazodone, carvedilol 5

Step 3: Switch Antihypertensive Medications (Critical Step)

Switch BP-lowering medications that worsen orthostatic hypotension to alternative BP-lowering therapy—do not simply de-intensify therapy 1. This is a Class I recommendation with Level A evidence.

Preferred Antihypertensive Agents for Patients with Orthostatic Hypotension:

1. Angiotensin receptor blockers (ARBs) or ACE inhibitors at maximum tolerated dose 2, 5
2. Dihydropyridine calcium channel blockers (CCBs) 2, 5
3. Thiazide-type and thiazide-like diuretics (use low-dose if needed) 2

Agents to AVOID or Use with Caution:

• Beta-blockers: Preferably not used unless compelling indications exist (post-MI, angina, heart failure) 1
• Alpha-blockers: Should be avoided 1, 3, 1
• High-dose diuretics: Can worsen volume depletion 1

Step 4: Special Considerations for Older and Frail Patients

For patients aged ≥85 years and/or with moderate-to-severe frailty:

• Consider long-acting dihydropyridine CCBs or RAS inhibitors as first-line 1
• Follow with low-dose diuretic if tolerated 1
• Avoid beta-blockers and alpha-blockers unless compelling indications 1

If BP drops with progressing frailty, consider deprescription of BP-lowering medications 1.

Step 5: Pharmacological Treatment for Orthostatic Hypotension (If Needed)

If non-pharmacological measures and medication switching are insufficient:

First-line agents:

• Midodrine (5-20 mg three times daily): Most evidence-based, increases BP in both supine and upright posture 4, 5, 7, 8

  • Caution: Can cause supine hypertension in ~25% of patients; avoid late afternoon/evening doses 9

• Fludrocortisone (0.1-0.3 mg once daily): Stimulates renal sodium retention and expands fluid volume 4, 7, 8

Second-line agents:

• Pyridostigmine: Facilitates cholinergic neurotransmission in autonomic ganglia 5, 7, 10
• Atomoxetine: Blocks norepinephrine reuptake in nerve terminals 5, 7, 10
• Droxidopa: FDA-approved pressor agent 7, 8

For specific situations:

• Acarbose: For postprandial hypotension 5
• Octreotide: For postprandial hypotension 4

Blood Pressure Targets

Continue to target systolic BP of 120-129 mmHg in most adults, provided treatment is well tolerated 1. Recent evidence suggests that more intensive BP therapy may actually reduce orthostatic hypotension and prevent cardiovascular disease with minimal effects on hypotensive events 11.

Maintain diastolic BP >60 mmHg in older adults 2.

Common Pitfalls to Avoid

1. Do not automatically reduce antihypertensive therapy when orthostatic hypotension is discovered—this leaves hypertension undertreated and may worsen outcomes 1

2. Do not use combination of two RAS blockers (ACE inhibitor + ARB) 1

3. Do not ignore supine hypertension: Many patients with orthostatic hypotension have supine hypertension, requiring careful timing of medications 5, 6

4. Do not prescribe midodrine late in the day: Risk of supine hypertension at night 9

Monitoring Strategy

• Assess orthostatic vital signs at each visit when adjusting therapy 2
• Monitor for both hypotensive symptoms (dizziness, falls, syncope) and cardiovascular outcomes
• Check for supine hypertension if using pressor agents 5
• Maintain BP-lowering drug treatment lifelong if well tolerated, even beyond age 85 1